PFIZER, MODERNA: and... action!

This is what happened this week. Pfizer announced that basically its vaccine works well and is ready for distribution. The market immediately shot its stock from $36 to $42. Next, people started commenting that having the vaccine ready is not enough – there are quite a few problems around it, such as storage, delivery, pricing, etc. And the market went “ok then, I’m getting back down” – so the stock dropped to almost exactly where it was before the spike. Will it drop further? Possible, but the upside potential is still there – technically, and fundamentally. Very probably, in a week or so, the share price will penetrate $39, just on a milted upward curve. But that’s not the most interesting thing: Moderna has just announced that its vaccine is also waiting for the release of the trial results. Let’s look at the chart.

Moderna share price was below 75$ when the announcement was made. Momentarily, the stock went all the way to $88 – a more than 10% rise just in a couple of days. So far, it is staying in that range but will it continue to $95? That may depend on what the news are on the trial results. If they are as good – or, preferably, better than – those of Pfizer, very probably it will go up to $88 and beyond. Otherwise, it will drop the same as Pfizer did, to $75. Therefore, follow the news from Moderna and act quickly if you want to benefit from those movements.

Don't know how to trade stocks? Here are some simple steps.

First of all, be sure you’ve downloaded Metatrader 5.FBS allows you to trade stocks only through this software.
Open the MT5 account in your personal area.
Reveal all trading instruments by clicking “show all” at the “Market Watch” window.
Start trading!

Gaspar Markosyan

View all articles author